SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001140361-23-058681
Filing Date
2023-12-20
Accepted
2023-12-20 16:59:16
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A ny20013527x3_defa14a.htm DEFA14A 22880
2 logo_rmehra.jpg GRAPHIC 11745
3 logo_seelostherapeutics.jpg GRAPHIC 35790
  Complete submission text file 0001140361-23-058681.txt   89260
Mailing Address 300 PARK AVENUE 2ND FLOOR NEW YORK NY 10022
Business Address 300 PARK AVENUE 2ND FLOOR NEW YORK NY 10022 (646) 293-2100
SEELOS THERAPEUTICS, INC. (Filer) CIK: 0001017491 (see all company filings)

IRS No.: 870449967 | State of Incorp.: NV | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-22245 | Film No.: 231501996
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)